Supplemental Methods from A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma

Open Access

Publisher Website

31 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/1078-0432.22476704

Abstract

Additional description of correlative immunologic assays

Keywords